RadNet
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.1b | 1.3b | 1.4b | 1.6b | 1.8b | 1.9b | 2.0b |
% growth | (7 %) | 23 % | 9 % | 13 % | 10 % | 8 % | 5 % |
EBITDA | 208m | 265m | 243m | 307m | 277m | 307m | 327m |
% EBITDA margin | 19 % | 20 % | 17 % | 19 % | 16 % | 16 % | 16 % |
Profit | (14.8m) | 24.7m | 10.7m | 3.0m | 23.2m | 58.1m | 67.8m |
% profit margin | (1 %) | 2 % | 1 % | - | 1 % | 3 % | 3 % |
EV / revenue | 0.9x | 1.2x | 0.8x | 1.5x | 2.8x | 2.5x | 2.4x |
EV / EBITDA | 4.9x | 6.1x | 4.4x | 7.7x | 17.7x | 16.0x | 15.0x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | $225m | Post IPO Equity |
* | $245k | Post IPO Equity | |
* | N/A | $230m | Post IPO Equity |
* | $1.2b | Post IPO Debt | |
Total Funding | - |
Related Content
Recent News about RadNet
EditRadNet, Inc. operates a network of 350 outpatient radiology centers across seven states in the United States, specializing in advanced imaging services. With over 35 years of expertise, RadNet is at the forefront of radiology, utilizing cutting-edge technology and artificial intelligence to enhance diagnostic accuracy and patient care. The company serves a diverse client base, including healthcare providers, patients, regulators, and payers, offering a comprehensive portfolio of radiology solutions. RadNet's business model revolves around providing high-quality imaging services, which generate revenue through patient fees and partnerships with healthcare institutions. The company is committed to innovation, continuously pioneering research and leveraging best practices in radiology to maintain its leadership position in the market.
Keywords: outpatient imaging, radiology, artificial intelligence, diagnostic accuracy, patient care, healthcare providers, innovation, technology solutions, research, partnerships.